Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Biomerica stock | $6.37

Own Biomerica stock in just a few minutes.

Fact checked

Biomerica, Inc is a diagnostics & research business based in the US. Biomerica shares (BMRA) are listed on the NASDAQ and all prices are listed in US Dollars. Biomerica employs 65 staff and has a trailing 12-month revenue of around USD$6.6 million.

How to buy shares in Biomerica

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Biomerica. Find the stock by name or ticker symbol: BMRA. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Biomerica reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$6.37, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Biomerica, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Biomerica. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Biomerica share price

Use our graph to track the performance of BMRA stocks over time.

Biomerica shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$6.37
52-week rangeUSD$2.05 - USD$12.75
50-day moving average USD$6.32
200-day moving average USD$7.1629
Wall St. target priceUSD$11.13
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.26

Buy Biomerica shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Biomerica stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biomerica price performance over time

Historical closes compared with the close of $6.37 from 2020-12-09

1 week (2021-01-08) 19.51%
1 month (2020-12-16) 14.98%
3 months (2020-10-15) -12.62%
6 months (2020-07-15) -33.37%
1 year (2020-01-15) 125.09%
2 years (2019-01-15) 207.00%
3 years (2018-01-12) 28.69%
5 years (2016-01-15) 409.60%

Biomerica financials

Revenue TTM USD$6.6 million
Gross profit TTM USD$1.8 million
Return on assets TTM -19.62%
Return on equity TTM -42.98%
Profit margin -52.43%
Book value $1.068
Market capitalisation USD$58.4 million

TTM: trailing 12 months

Shorting Biomerica shares

There are currently 769,454 Biomerica shares held short by investors – that's known as Biomerica's "short interest". This figure is 3.7% down from 799,263 last month.

There are a few different ways that this level of interest in shorting Biomerica shares can be evaluated.

Biomerica's "short interest ratio" (SIR)

Biomerica's "short interest ratio" (SIR) is the quantity of Biomerica shares currently shorted divided by the average quantity of Biomerica shares traded daily (recently around 87042.307692308). Biomerica's SIR currently stands at 8.84. In other words for every 100,000 Biomerica shares traded daily on the market, roughly 8840 shares are currently held short.

However Biomerica's short interest can also be evaluated against the total number of Biomerica shares, or, against the total number of tradable Biomerica shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Biomerica's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Biomerica shares in existence, roughly 70 shares are currently held short) or 0.08% of the tradable shares (for every 100,000 tradable Biomerica shares, roughly 80 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Biomerica.

Find out more about how you can short Biomerica stock.

Biomerica share dividends

We're not expecting Biomerica to pay a dividend over the next 12 months.

Have Biomerica's shares ever split?

Biomerica's shares were split on 7 April 2016.

Biomerica share price volatility

Over the last 12 months, Biomerica's shares have ranged in value from as little as $2.05 up to $12.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biomerica's is -0.4856. This would suggest that Biomerica's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biomerica has bucked the trend.

Biomerica overview

Biomerica, Inc., a biomedical technology company, together with its subsidiaries, develops, patents, manufactures, and markets diagnostic and therapeutic products or detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy that is designed to allow physicians to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms; Helicobacter pylori products; and develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site